16:04 EDT Acurx (ACXP) files to sell 8.4M shares of common stock for holders
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACXP:
- Optimistic Buy Rating for Acurx Pharmaceuticals Amidst Financial Challenges and Promising Ibezapolstat Data
- Strategic Phase 3 Trials and Unique Microbiome Effects Drive Buy Rating for Acurx Pharmaceuticals
- Acurx Pharmaceuticals Reports 2024 Results and Advances Trials
- Acurx Pharmaceuticals’ Optimistic Earnings Call Highlights Clinical Progress
- Acurx price target lowered to $5 from $14 at Alliance Global Partners